{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:33:58Z","timestamp":1791588838893,"version":"4.3.4"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174343"],"award-info":[{"award-number":["82174343"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019091","name":"Key Research and Development Program of Hunan Province of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M773968"],"award-info":[{"award-number":["2025M773968"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Yixintai (YXT) medicine for chronic heart failure (CHF), has demonstrated safety and efficacy in the treatment of CHF. However, its precise mechanistic actions require further elucidation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study identified components in YXT using the UHPLC-QE-MS technique. A rat CHF model was created by ligating the left anterior descending coronary artery and an inflammatory injury model was induced in H9c2 cells using lipopolysaccharide (LPS) to evaluate the efficacy of YXT. After YXT treatment, changes in fecal gut microbiota and serum BAs profiles in rats were evaluated utilizing 16S rRNA sequencing and UHPLC-MS\/MS techniques. Additionally, western blot (WB) and polymerase chain reaction (PCR) assays were conducted to assess the expression levels of TGR5 in both myocardial tissue and H9c2 cells. Cyclic adenosine monophosphate (cAMP), B-type natriuretic peptide (BNP), interleukin-1 beta (IL-1\u03b2), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-\u03b1) levels were also measured using enzyme-linked immunosorbent assay (ELISA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 1049 components were identified in YXT. YXT treatment effectively attenuated the inflammatory reaction, reduced serum BNP levels, alleviated the pathological changes in the colon and myocardium, and improved cardiac function in CHF rats. YXT treatment significantly improved gut microbiota diversity in CHF rats, enhancing beneficial bacterial populations and serum bile acid levels, while reducing the abundance of detrimental bacteria. Furthermore, YXT treatment enhanced TGR5 expression in the myocardial tissue and H9c2 cells of CHF rats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings suggest that YXT exerts its therapeutic benefits by reshaping the gut microbiota, modulating bile acid metabolism, and activating TGR5.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2025.1672313","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:20:51Z","timestamp":1764174051000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Yixintai treats chronic heart failure in rats by regulating gut microbiota and bile acid"],"prefix":"10.3389","volume":"16","author":[{"given":"Min","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jama.2020.13310","article-title":"Heart failure.","volume":"324","author":"Baman","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10741-024-10450-6","article-title":"GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction.","volume":"30","author":"Bonfioli","year":"2025","journal-title":"Heart Fail. Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11154-019-09519-7","article-title":"The gut microbiome and heart failure: A better gut for a better heart.","volume":"20","author":"Branchereau","year":"2019","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12016-019-08731-2","article-title":"Comprehensive analysis of serum and fecal bile acid profiles and interaction with gut microbiota in primary biliary cholangitis.","volume":"58","author":"Chen","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41598-017-18756-2","article-title":"Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients.","volume":"8","author":"Cui","year":"2018","journal-title":"Sci. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.3390\/biomedicines10112762","article-title":"Diversities in the gut microbial patterns in patients with atherosclerotic cardiovascular diseases and certain heart failure phenotypes.","volume":"10","author":"Drapkina","year":"2022","journal-title":"Biomedicines"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e12462","DOI":"10.1111\/1755-5922.12462","article-title":"TGR5 activation induces cytoprotective changes in the heart and improves myocardial adaptability to physiologic, inotropic, and pressure-induced stress in mice.","volume":"36","author":"Eblimit","year":"2018","journal-title":"Cardiovasc. Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.medcli.2019.06.006","article-title":"Impact of intestinal microbiota in patients with heart failure: A systematic review.","volume":"153","author":"Formiga","year":"2019","journal-title":"Med. Clin."},{"key":"B9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3390\/biom8040159","article-title":"Overview of bile acids signaling and perspective on the signal of ursodeoxycholic acid, the most hydrophilic bile acid, in the heart.","volume":"8","author":"Hanafi","year":"2018","journal-title":"Biomolecules"},{"key":"B10","doi-asserted-by":"publisher","first-page":"109726","DOI":"10.1016\/j.celrep.2021.109726","article-title":"Gut microbiota-mediated secondary bile acids regulate dendritic cells to attenuate autoimmune uveitis through TGR5 signaling.","volume":"36","author":"Hu","year":"2021","journal-title":"Cell Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"102179","DOI":"10.1016\/j.cpcardiol.2023.102179","article-title":"Unveiling the relationship between gut microbiota and heart failure: Recent understandings and insights.","volume":"49","author":"Jain","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","article-title":"Global epidemiology of heart failure.","volume":"21","author":"Khan","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.3390\/nu16152551","article-title":"Cholelithiasis, gut microbiota and bile acids after bariatric surgery-can cholelithiasis be prevented by modulating the microbiota? A literature review.","volume":"16","author":"Komorniak","year":"2024","journal-title":"Nutrients"},{"key":"B14","doi-asserted-by":"publisher","first-page":"118680","DOI":"10.1016\/j.jep.2024.118680","article-title":"Coptisine alleviates colitis through modulating gut microbiota and inhibiting TXNIP\/NLRP3 inflammasome.","volume":"335","author":"Li","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12866-021-02202-5","article-title":"Changes of gut microbiome composition and metabolites associated with hypertensive heart failure rats.","volume":"21","author":"Li","year":"2021","journal-title":"BMC Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1005111","DOI":"10.1155\/2022\/1005111","article-title":"Gut microbiota and inflammatory cytokine changes in patients with ankylosing spondylitis.","volume":"2022","author":"Liu","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"619207","DOI":"10.1155\/2013\/619207","article-title":"Regulation of DDAH1 as a potential therapeutic target for treating cardiovascular diseases.","volume":"2013","author":"Liu","year":"2013","journal-title":"Evid. Based Compl. Alternat. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1321395","DOI":"10.3389\/fimmu.2024.1321395","article-title":"Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.","volume":"15","author":"Luqman","year":"2024","journal-title":"Front. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/ejhf.1792","article-title":"Gut dysbiosis and heart failure: Navigating the universe within.","volume":"22","author":"Madan","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"B20","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cardfail.2017.06.007","article-title":"Increased secondary\/primary bile acid ratio in chronic heart failure.","volume":"23","author":"Mayerhofer","year":"2017","journal-title":"J. Card. Fail."},{"key":"B21","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.cardfail.2015.09.017","article-title":"Intersections between microbiome and heart failure: Revisiting the gut hypothesis.","volume":"21","author":"Nagatomo","year":"2015","journal-title":"J. Card. Fail."},{"key":"B22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1631\/jzus.B1400327","article-title":"Cross-talk between bile acids and intestinal microbiota in host metabolism and health.","volume":"16","author":"Nie","year":"2015","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1997560","DOI":"10.1080\/19490976.2021.1997560","article-title":"Bacteroidota and Lachnospiraceae integration into the gut microbiome at key time points in early life are linked to infant neurodevelopment.","volume":"13","author":"Oliphant","year":"2021","journal-title":"Gut Microbes"},{"key":"B24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jchf.2015.10.009","article-title":"Pathogenic gut flora in patients with chronic heart failure.","volume":"4","author":"Pasini","year":"2016","journal-title":"JACC Heart Fail"},{"key":"B25","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1152\/physrev.00049.2019","article-title":"Molecular physiology of bile acid signaling in health, disease, and aging.","volume":"101","author":"Perino","year":"2021","journal-title":"Physiol. Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.carrev.2005.07.001","article-title":"A novel method for safe and accurate left anterior descending coronary artery ligation for research in rats.","volume":"6","author":"Samsamshariat","year":"2005","journal-title":"Cardiovasc. Revasc. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1080\/01480545.2021.1894707","article-title":"Attenuation of lipid metabolic abnormalities, proinflammatory cytokines, and matrix metalloproteinase expression by biochanin-A in isoproterenol-induced myocardial infarction in rats.","volume":"45","author":"Sangeethadevi","year":"2022","journal-title":"Drug. Chem. Toxicol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: A comprehensive and updated review of epidemiology.","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41569-018-0108-7","article-title":"Dietary metabolism, the gut microbiome, and heart failure.","volume":"16","author":"Tang","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism.","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1080\/14786419.2020.1855167","article-title":"Saffloflavone, a new flavonoid from the flowers of Carthamus tinctorius L. and its cardioprotective activity.","volume":"36","author":"Wang","year":"2022","journal-title":"Nat. Prod. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"828061","DOI":"10.3389\/fphar.2022.828061","article-title":"Calycosin as a novel PI3K activator reduces inflammation and fibrosis in heart failure through AKT-IKK\/STAT3 axis.","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.2174\/1381612823666170925163427","article-title":"A review of chinese herbal medicine for the treatment of chronic heart failure.","volume":"23","author":"Wang","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2147\/DDDT.S448140","article-title":"Network and experimental pharmacology on mechanism of yixintai regulates the TMAO\/PKC\/NF-\u03baB signaling pathway in treating heart failure.","volume":"18","author":"Wang","year":"2024","journal-title":"Drug Design Dev. Therapy"},{"key":"B35","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/19490976.2019.1674124","article-title":"Diversification of host bile acids by members of the gut microbiota.","volume":"11","author":"Winston","year":"2020","journal-title":"Gut Microbes"},{"key":"B36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00392-022-02008-z","article-title":"Heart failure-related quality-of-life impairment after myocardial infarction.","volume":"112","author":"Wohlfahrt","year":"2023","journal-title":"Clin. Res, Cardiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1007\/s12265-024-10529-3","article-title":"Gut microbiota as predictive biomarker for chronic heart failure in patients with different nutritional risk.","volume":"17","author":"Yang","year":"2024","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/biomedicines11020442","article-title":"The interaction of gut microbiota and heart failure with preserved ejection fraction: From mechanism to potential therapies.","volume":"11","author":"Yu","year":"2023","journal-title":"Biomedicines"},{"key":"B39","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.healun.2020.02.004","article-title":"Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant.","volume":"39","author":"Yuzefpolskaya","year":"2020","journal-title":"J. Heart Lung Transplant"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1152349","DOI":"10.3389\/fcimb.2023.1152349","article-title":"Relationship between disorders of the intestinal microbiota and heart failure in infants with congenital heart disease.","volume":"13","author":"Zhang","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.14336\/AD.2022.0817","article-title":"The role of bile acids in cardiovascular diseases: From mechanisms to clinical implications.","volume":"14","author":"Zhang","year":"2023","journal-title":"Aging Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"9173","DOI":"10.18632\/aging.103187","article-title":"Dietary type 2 resistant starch improves systemic inflammation and intestinal permeability by modulating microbiota and metabolites in aged mice on high-fat diet.","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging"},{"key":"B43","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1152\/japplphysiol.01149.2014","article-title":"Heart failure with preserved ejection fraction: Defining the function of ROS and NO.","volume":"119","author":"Zuo","year":"2015","journal-title":"J. Appl. Physiol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1672313\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:20:51Z","timestamp":1764174051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1672313\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":43,"alternative-id":["10.3389\/fmicb.2025.1672313"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1672313","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"article-number":"1672313"}}